Header and Body 4

Advantages

  • The peptide inhibitors are potent and selective towards Bfl-1 with >100-fold selectivity over other anti-apoptotic proteins
  • The peptide inhibitors can also be used as diagnostic tools to profile cells for Bfl-1 dependency